Primary Record
Diprenorphine
- In stock
- 2,000 g
- Purity
- 99.1 %
- CAS
- 14357-78-9
Compound Identifiers & Properties
- CAS
- 14357-78-9
- PubChem CID
- 443408
- SMILES
- CC(C)([C@H]1C[C@@]23CC[C@@]1([C@H]4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O
- Canonical SMILES
- CO[C@]12CC[C@@]3(C[C@@H]1C(C)(C)O)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5
Names & Synonyms
- Diprenorphine
- Diprenorfina
- Diprenorfin
- Diprenorphinum
- Revivon
- M50-50 Injection
- Diprenorphine (INN)
- M 5050 Injection
- DIPRENORPHINE-HCl
- Diprenorphine [INN:BAN]
- 14357-78-9
- AC1L9ELZ
- Diprenorfina [INN-Spanish]
- Diprenorphinum [INN-Latin]
- RefChem:388941
- 1F0L5N25ZZ
- UNII-1F0L5N25ZZ
- DEA No. 9058
- DIPRENORPHINE [MI]
- D0O6SB
- DIPRENORPHINE [INN]
- CHEMBL281786
- SCHEMBL164910
- DTXSID00903941
- CHEBI:4650
- GTPL1617
- RX 5050M
- SCHEMBL29631595
- C26H35NO4
- EINECS 238-325-7
- OIJXLIIMXHRJJH-KNLIIKEYSA-N
- DTXCID101331891
- ZINC4102215
- BDBM50001714
- C26-H35-N-O4
- CID443408
- M5050
- AKOS024457358
- M. 5050
- DB01548
- FD03511
- M-5050
- DA-52578
- M50-50
- HY-107742
- B5353
- Diprenorphine; M 5050; M 5050 Injection
- NS00069824
- C11794
- D07863
- M 5050
- Q424009
- (1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-16-(2-hydroxypropan-2-yl)-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol
- 21-Cyclopropyl-6,7,8,14-tetrahydro-7alpha-(1-hydroxy-1-methylethyl)-6,14-endo-ethanooripavine
- 6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-.alpha.,.alpha.-dimethyl-, (5.alpha.,7.alpha.)-
- 6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha,alpha-dimethyl-, (5alpha,7alpha)-
- 6,14-endo-Ethanotetrahydrooripavine, 21-cyclopropyl-7.alpha.-(1-hydroxy-1-methylethyl)-
- epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha,alpha-dimethyl-, (5alpha,7alpha)-
- (18R)-17-(Cyclopropylmethyl)-18-(2-hydroxypropan-2-yl)-6-methoxy-5alpha,6beta,14beta-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol
- (1S,2R,6S,14R,15R,16R)-3-(cyclopropylmethyl)-16-(2-hydroxypropan-2-yl)-15-methoxy-13-oxa-3-azahexacyclo(13.2.2.12,?.01,?.0?,1?.0?,12)icosa-7,9,11-trien-11-ol
- (1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-16-(2-hydroxypropan-2-yl)-15-methoxy-13-oxa-5-azahexacyclo(13.2.2.12,8.01,6.02,14.012,20)icosa-8(20),9,11-trien-11-ol
- (5alpha,7alpha)-17-(Cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha,alpha-dimethyl-6,14-ethenomorphinan-7-methanol
- 1-N-Cyclopropylmethyl-6,7,8,14-tetrahydro-6,14-endoethano-7-(2'-hydroxy-2'-propyl)nororipavine; Diprenorphine; M 5050; M 5050 Injection; N-(Cyclopropylmethyl)-19-methylnororvinol; RX 5050M; (5alpha,7alpha)-17-(Cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha,alpha-dimethyl-6,14-ethenomorphinan-7-methanol; 21-Cyclopropyl-7alpha-(1-hydroxy-1-methylethyl)-6,14-endo-ethanotetrahydrooripavine
- 17-(Cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-?,?-dimethyl-6,14-ethenomorphinan-7-methanol
- 2-[3-cyclopropylmethyl-11-hydroxy-15-methoxy-(1S,2R,6S,14R,15R,16R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-2-propanol
- 2-[3-cyclopropylmethyl-11-hydroxy-15-methoxy-(1S,2R,6S,14R,15R,16R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-2-propanol(diprenorphine)
- 2-[3-cyclopropylmethyl-11-hydroxy-15-methoxy-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7(12),8,10-trien-16-yl]-2-propanol
- 21-cyclopropyl-6,7,8,14-tetrahydro-7-alpha-(1-hydroxy-1-methylethyl)-6,14-endo-ethanooripavine
- 238-325-7
- 6,14-endo-Ethanotetrahydrooripavine, 21-cyclopropyl-7a-(1-hydroxy-1-methylethyl)- (8CI) 1-N-Cyclopropylmethyl-6,7,8,14-tetrahydro-6,14-endoethano-7-(2'-hydroxy-2'-propyl)nororipavine
- 6,14-ethenomorphinan-3-ol, 17-(cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-18-(1-hydroxy-1-methylethyl)-6-methoxy-, (5alpha,6beta,14beta,18R)-
- 6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha,alpha-dimethyl-, (5alpha,7alpha)- (9CI)